Neuromuscular Stimulation Articles & Analysis
14 news found
Brandon Nokes, Professor Atul Malhotra, and other collaborators, is based on a post-hoc analysis of 65 participants with mild obstructive sleep apnea (OSA) who completed sleep testing before and after six weeks of genioglossus (tongue muscle) neuromuscular electrical stimulation (NMES) with eXciteOSA. The first of its kind, eXciteOSA is an FDA-authorized, ...
” OSA is a progressive disease, often starting with primary snoring, affecting nearly 1 billion adults aged 30 to 69 globally.1 Used for only 20 minutes per day during the initiation period, and then twice per week thereafter for maintenance, eXciteOSA targets a primary root cause of mild OSA by delivering neuromuscular electric stimulation to increase ...
” Unlike devices used while patients are asleep, eXciteOSA is the first marketed device designed to be used while awake. It works by applying neuromuscular electrical stimulation (NMES) on the genioglossus muscle – the major muscle that forms the tongue mass. ...
Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has received the prestigious GOOD DESIGN® Award in the Medical category. ...
Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has been cleared by the U.S. ...
” eXciteOSA® is the only clinically proven daytime intraoral neuromuscular stimulation device to improve the quality of sleep by reducing sleep apnea and snoring significantly when used for 20 minutes once a day for six weeks1-4. ...
Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients, and improving patient outcomes. Liberate Medical today ...
Two pilot randomized controlled trials, recently completed in Europe and Australia, indicated that compared with placebo stimulation, the VentFree may reduce ventilation duration and ICU length of stay. ...
On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal system), respiratory dynamics (respiratory neuromuscular stimulator), and cuff pressure gauge (balloon manometers). ...
The donated medical equipment includes all products independently developed by Yaguo, including an intelligent bionic cough simulator, a respiratory neuromuscular stimulator, and a cuff-pressure gauge. The products are donated directly to Wuhan city’s Xiehe Hospital, Tongji Hospital, Tongren Hospital, Pu’ai Hospital, Zhongnan Hospital as well as to ...
We were to present our three core products i.e. Cuff Pressure Gauge, Neuromuscular Stimulator and the Bionic Cough Simulator. We reached one day prior to look for the arrangements andthe conference officially started on 27th of January with the Hall utilized to its full capacity by the booths of various healthcare companies from all around the world. ...
The VentFree stimulator applies proprietary non-invasive electrical stimulation to the abdominal muscles during exhalation. ...
The VentFree Muscle Stimulator, which received Breakthrough Device Designation from the FDA in January, is an electrotherapy device that applies stimulation to the abdominal wall muscles in synchrony with mechanical ventilation. ...
Liberate Medical, a clinical stage medical device company, focused on the development of novel non-invasive neuromuscular electrical stimulation devices to address pulmonary conditions, announced today that the U.S. ...